Abstract | INTRODUCTION: Significant progress has recently been made in the pharmacological treatment of arrhythmias. This concerns mainly atrial fibrillation, which affects millions of patients. AREAS COVERED: This review covers recent, clinically relevant developments in arrhythmia treatment, especially with regard to novel agents for the management of atrial fibrillation: dronedarone for rhythm control, vernakalant for pharmacological conversion, and advances in antithrombotic treatment. The field of pharmacological treatment of ventricular arrhythmias is also briefly discussed. Relevant papers were identified by an extensive Pubmed search using appropriate keywords. EXPERT OPINION:
|
Authors | Nikolaos Dagres, Philipp Sommer, Maria Anastasiou-Nana, Gerhard Hindricks |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 12
Issue 9
Pg. 1359-67
(Jun 2011)
ISSN: 1744-7666 [Electronic] England |
PMID | 21352091
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Animals
- Anti-Arrhythmia Agents
(pharmacology, therapeutic use)
- Atrial Fibrillation
(drug therapy, prevention & control)
- Humans
|